Measuring the strength of national pharmaceutical intellectual property regimes in eight countries: Using a pharmaceutical IP index to benchmark India "apparet id quidem etiam caeco" (that is obvious even to a blind man), Titus Livius (Ab urbe condita, XXXII, 34)

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)573-591
Number of pages19
JournalJournal of World Investment and Trade
Volume8
Issue number4
DOIs
StatePublished - 2007

Bibliographical note

Funding Information:
* Senior Lecturer, School of Public Health, University of Haifa ? Director of Research, Stockholm-Network. The author wishes to thank Pfizer Pharmaceuticals for providing him with a grant for undertaking this research and the field study to India. Email â?¹[email protected].â?º M . P . Pugatch, 'Measuring the Strength of National Pharmaceutical Intellectual Property Regimes: Creating a New Pharmaceutical IP Index', Journal of World Intellectual Property, vol. 9:4, July 2006, pp. 373-391.

ASJC Scopus subject areas

  • Business and International Management
  • Political Science and International Relations
  • General Economics, Econometrics and Finance
  • Law

Cite this